NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,178 filers reported holding NOVARTIS A G in Q2 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,820,548 | -36.8% | 116,047 | -37.3% | 0.23% | -38.7% |
Q2 2023 | $18,691,156 | +7.1% | 185,226 | -2.3% | 0.38% | +1.9% |
Q1 2023 | $17,447,892 | +933.4% | 189,651 | +919.0% | 0.37% | +687.2% |
Q4 2022 | $1,688,390 | -88.8% | 18,611 | -90.6% | 0.05% | -88.1% |
Q3 2022 | $15,089,000 | -17.0% | 198,515 | -7.7% | 0.40% | -11.0% |
Q2 2022 | $18,178,000 | -16.1% | 215,050 | -12.9% | 0.44% | -4.3% |
Q1 2022 | $21,676,000 | +10.3% | 247,016 | +9.9% | 0.46% | +8.2% |
Q4 2021 | $19,652,000 | -0.8% | 224,666 | -7.3% | 0.43% | -0.2% |
Q3 2021 | $19,811,000 | -7.9% | 242,252 | +2.7% | 0.43% | -10.0% |
Q2 2021 | $21,517,000 | +13.0% | 235,822 | +7.8% | 0.48% | +6.0% |
Q1 2021 | $19,038,000 | +44.5% | 218,770 | +56.7% | 0.45% | +33.0% |
Q4 2020 | $13,174,000 | – | 139,611 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |